Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SGK3-PROTAC1 is a proteolysis-targeting chimera (PROTAC) containing the serum/glucocorticoid-regulated kinase 3 (SGK3) inhibitor 308-R conjugated to VHL ligand 1 (Item No. 21591) via an alkyl linker with two PEG units.1 It inhibits SGK3, SGK1, and p70 ribosomal S6 kinase 1 (S6K1; IC50s = 0.3, 0.22, and 1.8 µM, respectively) but selectively induces degradation of SGK3 over SGK1 and S6K1 in HEK293 cells when used at concentrations ranging from 0.3 to 3 µM. SGK3-PROTAC1 (0.3 µM) potentiates cell growth inhibition induced by GDC-0941 (Item No. 11600) in CAMA-1 and ZR-75-1 breast cancer cells. It also reduces SGK3 levels, sodium-dependent phosphate transporter 1 (PiT-1) levels, and calcium deposition induced by high levels of inorganic phosphate (Pi) in primary mouse vascular smooth muscle cells (VSMCs) when used at a concentration of 2.5 µM.2
WARNING This product is not for human or veterinary use.
1. Design and characterization of SGK3-
2. SGK3 promotes vascular calcification via Pit-